22.01.2014 22:31:00

Abbott Laboratories -- Moody's: Abbott's upsized buyback program highlights more aggressive financial policies

New York, January 22, 2014 -- Moody's said that Abbott Laboratories' (A1 negative) announcement on 22 January that it plans to repurchase $2.0 billion in shares during 2014 is credit negative but has no effect on the company's ratings at this time. For additional information, please see Moody's Issuer Comment on Abbott Laboratories on www.moodys.com.

Vollständigen Artikel bei Moodys lesen